241 related articles for article (PubMed ID: 16517834)
1. Results of three-dimensional conformal radiotherapy and thalidomide for advanced hepatocellular carcinoma.
Hsu WC; Chan SC; Ting LL; Chung NN; Wang PM; Ying KS; Shin JS; Chao CJ; Lin GD
Jpn J Clin Oncol; 2006 Feb; 36(2):93-9. PubMed ID: 16517834
[TBL] [Abstract][Full Text] [Related]
2. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy of 3-dimensional conformal hypofractionated single high-dose radiotherapy combined with transcatheter arterial chemoembolization for portal vein tumor thrombus in patients with hepatocellular carcinoma].
Wu DH; Chen LH
Ai Zheng; 2004 Jul; 23(7):825-8. PubMed ID: 15248921
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of high-dose three-dimensional conformal radiotherapy in hepatocellular carcinoma with portal vein thrombosis.
Rim CH; Yang DS; Park YJ; Yoon WS; Lee JA; Kim CY
Jpn J Clin Oncol; 2012 Aug; 42(8):721-9. PubMed ID: 22689916
[TBL] [Abstract][Full Text] [Related]
5. Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma.
Kim DY; Park W; Lim DH; Lee JH; Yoo BC; Paik SW; Kho KC; Kim TH; Ahn YC; Huh SJ
Cancer; 2005 Jun; 103(11):2419-26. PubMed ID: 15822130
[TBL] [Abstract][Full Text] [Related]
6. Treatment of portal vein tumor thrombosis of hepatoma patients with either stereotactic radiotherapy or three-dimensional conformal radiotherapy.
Lin CS; Jen YM; Chiu SY; Hwang JM; Chao HL; Lin HY; Shum WY
Jpn J Clin Oncol; 2006 Apr; 36(4):212-7. PubMed ID: 16613896
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic factor of primary liver cancer treated by hypofractionated three-dimensional conformal radiotherapy].
Liang SX; Jiang GL; Zhu XD; Fu XL; Li FX; Huang QF; Wang AY; Chen L; Lu HJ
Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):613-5. PubMed ID: 16438872
[TBL] [Abstract][Full Text] [Related]
8. Potential prognostic benefits of radiotherapy as an initial treatment for patients with unresectable advanced hepatocellular carcinoma with invasion to intrahepatic large vessels.
Nakazawa T; Adachi S; Kitano M; Isobe Y; Kokubu S; Hidaka H; Ono K; Okuwaki Y; Watanabe M; Shibuya A; Saigenji K
Oncology; 2007; 73(1-2):90-7. PubMed ID: 18337620
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma with main portal vein tumor thrombus: treatment with 3-dimensional conformal radiotherapy after portal vein stenting and transarterial chemoembolization.
Zhang XB; Wang JH; Yan ZP; Qian S; Du SS; Zeng ZC
Cancer; 2009 Mar; 115(6):1245-52. PubMed ID: 19156918
[TBL] [Abstract][Full Text] [Related]
10. alpha-fetoprotein response predicts survival benefits of thalidomide in advanced hepatocellular carcinoma.
Chen LT; Liu TW; Chao Y; Shiah HS; Chang JY; Juang SH; Chen SC; Chuang TR; Chin YH; Whang-Peng J
Aliment Pharmacol Ther; 2005 Aug; 22(3):217-26. PubMed ID: 16091059
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting the prognosis of patients with hepatocellular carcinoma invading the portal vein--a retrospective analysis using 952 consecutive HCC patients.
Koike Y; Nakagawa K; Shiratori Y; Shiina S; Imamura M; Sato S; Obi S; Teratani T; Hamamura K; Yoshida H; Omata M
Hepatogastroenterology; 2003; 50(54):2035-9. PubMed ID: 14696460
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional conformal radiotherapy for hepatocellular carcinoma with inferior vena cava invasion.
Igaki H; Nakagawa K; Shiraishi K; Shiina S; Kokudo N; Terahara A; Yamashita H; Sasano N; Omata M; Ohtomo K
Jpn J Clin Oncol; 2008 Jun; 38(6):438-44. PubMed ID: 18495749
[TBL] [Abstract][Full Text] [Related]
13. Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy.
Kim TH; Kim DY; Park JW; Kim SH; Choi JI; Kim HB; Lee WJ; Park SJ; Hong EK; Kim CM
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):225-31. PubMed ID: 17056199
[TBL] [Abstract][Full Text] [Related]
14. Effects of the combined treatment with thalidomide, megestrol and interleukine-2 in cirrhotic patients with advanced hepatocellular carcinoma. A pilot study.
Cappa FM; Cantarini MC; Magini G; Zambruni A; Bendini C; Santi V; Bernardi M; Trevisani F
Dig Liver Dis; 2005 Apr; 37(4):254-9. PubMed ID: 15788209
[TBL] [Abstract][Full Text] [Related]
15. [Three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
Zhou ZH; Liu LM; Cheng WW; Meng ZQ; Lin JH; Chen Z; Zhang XJ; Jiang GL
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):222-6. PubMed ID: 16875612
[TBL] [Abstract][Full Text] [Related]
16. [Three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for massive primary liver cancer].
Sun HW; Chen LH; Wei CJ; Zheng XK; Li QS; Guan J
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jun; 29(6):1133-6. PubMed ID: 19726341
[TBL] [Abstract][Full Text] [Related]
17. Conformal radiation therapy for portal vein tumor thrombosis of hepatocellular carcinoma.
Toya R; Murakami R; Baba Y; Nishimura R; Morishita S; Ikeda O; Kawanaka K; Beppu T; Sugiyama S; Sakamoto T; Yamashita Y; Oya N
Radiother Oncol; 2007 Sep; 84(3):266-71. PubMed ID: 17716760
[TBL] [Abstract][Full Text] [Related]
18. Three-dimensional conformal radiotherapy of unresectable hepatocellular carcinoma patients for whom transcatheter arterial chemoembolization was ineffective or unsuitable.
Kim TH; Kim DY; Park JW; Kim YI; Kim SH; Park HS; Lee WJ; Park SJ; Hong EK; Kim CM
Am J Clin Oncol; 2006 Dec; 29(6):568-75. PubMed ID: 17148993
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic effects of 3-dimensional conformal radiotherapy for small hepatocellular cancers and multi-factor analysis of the prognosis].
Wu DH; Chen LH
Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct; 23(10):1056-8. PubMed ID: 14559693
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of thalidomide in patients with unresectable hepatocellular carcinoma.
Lin AY; Brophy N; Fisher GA; So S; Biggs C; Yock TI; Levitt L
Cancer; 2005 Jan; 103(1):119-25. PubMed ID: 15565573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
